$2.98
+0.07 (+2.41%)
Open$2.89
Previous Close$2.91
Day High$3.02
Day Low$2.86
52W High$9.33
52W Low$3.59
Volume—
Avg Volume428.8K
Market Cap270.47M
P/E Ratio—
EPS$-2.14
SectorPharmaceuticals
Analyst Ratings
Buy
10 analysts
Price Target
+578.5% upside
Current
$2.98
$2.98
Target
$20.22
$20.22
$15.45
$20.22 avg
$24.58
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 513.07M | 419.27M | 70.84M |
| Net Income | -194,859,142 | -143,313,906 | 13.06M |
| Profit Margin | -38.0% | -36.1% | 18.4% |
| EBITDA | -94,112,182 | -73,062,493 | 20.07M |
| Free Cash Flow | — | — | 11.95M |
| Rev Growth | +22.4% | +22.4% | +2.1% |
| Debt/Equity | 0.05 | 0.05 | 0.16 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |